“A growing body of research shows that the lunasin peptide is one of the most important bioactive components of soy,” said Dr. Alfredo Galvez, the MPSC’s lead scientific advisor. “In creating LunaRich® for Reliv, we have maximized lunasin levels in a soy powder.”  The amount of lunasin in soybeans varies significantly based on seed, soil and environment. The MPSC refines specially selected soybeans grown exclusively for Reliv to maximize levels of lunasin in LunaRich®.

Dr. Galvez first discovered lunasin in 1996 during research at UC Berkley to improve the nutritional profile of soy protein. More than 40 peer-reviewed and published studies have documented lunasin’s health benefits. Research by 21 institutions supported by 27 public and private funding sources has resulted in nine patents.

“This is a significant step forward for Reliv and for nutrition science. LunaRich® is an extraordinary ingredient with solid clinical data behind it,” said Dr. Carl W. Hastings, Reliv’s chief scientific officer. “As scientists learn more about the mechanisms that make soy a nutritional superfood, Reliv is proud to lead the way in making the fruits of these discoveries available to all.”


Q.  How are seeds selected for the use of LunaRich®?

The LunaRich germ plasm soybean screening is conducted at the National Center for Soybean Biotechnology (NCSB), located in the Bond Life Sciences Center on the University of Missouri campus. Dr. Henry Nguyen and his staff have created a database of the traits of thousands of varieties of soybeans. Only those seed varieties that have the highest concentration of lunasin, the naturally occurring peptide behind many of soy’s remarkable health benefits, are selected for use in LunaRich.

These specific varieties are continually being enhanced through natural plant breeding, so each successive seed harvest yields even higher lunasin levels. That means that all soybeans used in LunaRich® are non-GMO, of the absolute highest quality and only getting better!